Premium
Intranasal desmopressin (Octim TM ): a safe and efficacious treatment option for children with bleeding disorders
Author(s) -
KHAIR K.,
BAKER K.,
MATHIAS M.,
BURGESS C.,
LIESNER R.
Publication year - 2007
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/j.1365-2516.2007.01519.x
Subject(s) - desmopressin , medicine , nasal administration , vasopressin , bleed , pediatrics , anesthesia , surgery , pharmacology
Summary. Desmopressin (1‐deamino‐8‐D‐arginine vasopressin (DDAVP)) has been shown to be an effective treatment option when administered both intravenously [1,2] and subcutaneously [3] to children with inherited bleeding disorders. We demostrate here, both the efficacy and acceptability of a new intranasal DDAVP preparation, providing a cost effective treatment with good outcomes for children with bleed disorders.